Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up

被引:0
作者
A Creak
E Hall
A Horwich
R Eeles
V Khoo
R Huddart
C Parker
C Griffin
M Bidmead
J Warrington
D Dearnaley
机构
[1] Academic Urology Unit,Joint Department of Physics
[2] The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust,undefined
[3] Clinical Trials and Statistics Unit (ICR-CTSU),undefined
[4] The Institute of Cancer Research,undefined
[5] Royal Marsden Hospital Trust and The Institute of Cancer Research,undefined
来源
British Journal of Cancer | 2013年 / 109卷
关键词
prostate cancer; radiotherapy; dose escalation; phase III randomised controlled trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:651 / 657
页数:6
相关论文
共 207 条
[1]  
Al-Mamgani A(2008)Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 72 980-988
[2]  
van Putten WL(2009)Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials Cancer 115 3446-3456
[3]  
Heemsbergen WD(2004)6-month androgen suppression plus radiation therapy JAMA 292 821-827
[4]  
van Leenders GJ(2012) radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial Lancet Oncol 13 43-54
[5]  
Slot A(2005)Conventional Br J Cancer 92 488-498
[6]  
Dielwart MF(2011) hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial Eur J Cancer 47 11-12
[7]  
Incrocci L(2007)Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects Lancet Oncol 8 475-487
[8]  
Lebesque JV(2011)Escalated-dose conformal radiotherapy for localised prostate cancer: long term overall survival results from the MRC RT01 randomised controlled trial Lancet Oncol 12 451-459
[9]  
Bria E(2009)Escalated-dose J Clin Epidemiol 62 29-36
[10]  
Cuppone F(1993) standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Radiother Oncol 29 219-220